Bulychev L E, Goncharova E P, P'iankova O G, Sergeev A N, Ryzhikov A B, P'iankov O V, Shishkina L N, Petrishchenko V A
Vestn Ross Akad Med Nauk. 1998(4):34-7.
White mice weighing 14-16 g were intranasally infected with LD50 of influenza virus (A/Aichi/2/68 strain). High levels both of virus and interferon were detected in the lung. Sufficient virus accumulation in the nasal cavity occurred with low interferon induction. At the same time high blood interferon levels corresponded to sporadic low viremia. Intraperitoneal injection of the interferon inducer ridostin (a pharmacological formulation of dsRNA) to BALB/c mice (18-20 g) in a dose of 5 mg/kg induced intensive blood accumulation of interferon with its peak at 8 hours postadministration (2560 U/0.2 ml), but interferon was not detected in the respiratory tract and brain of these mice. Intranasal (15 mg/kg) and aerogenic (0.4-0.6 mg/kg) administration of ridostin induced interferon mainly in the upper respiratory tract and lung. The regularities found are in agreement with the data on interferon induction by other dsRNA preparations, which makes it necessary to design dosage forms of interferon inducers for respiratory application in influenza.
将体重14 - 16克的小白鼠经鼻内接种流感病毒(A/爱知/2/68株)的半数致死量。在肺中检测到高水平的病毒和干扰素。鼻腔中出现了足够的病毒蓄积,而干扰素诱导水平较低。与此同时,高血液干扰素水平与散发性低病毒血症相对应。以5毫克/千克的剂量向BALB/c小鼠(18 - 20克)腹腔注射干扰素诱导剂利度司亭(双链RNA的一种药理制剂),诱导干扰素在血液中大量蓄积,给药后8小时达到峰值(2560单位/0.2毫升),但在这些小鼠的呼吸道和脑中未检测到干扰素。经鼻(15毫克/千克)和气雾吸入(0.4 - 0.6毫克/千克)利度司亭主要在上呼吸道和肺中诱导产生干扰素。所发现的规律与其他双链RNA制剂诱导干扰素的数据一致,这使得有必要设计用于流感呼吸道应用的干扰素诱导剂剂型。